issue

Apr 17, 2020

Volume 15 Number 17

This edition features articles on the incidence of major infections in PCI or CABG in the randomized SYNTAX trial; the PEPCAD NSTEMI trial randomising NSTEMI patients to drug-coated balloon or stents; a study of LAAO vs non-vitamin K antagonist oral anticoagulants; a look at the question of whether and when a patient is too old for TAVI; and the results of the TRICAVAL trial for severe tricuspid regurgitation comparing the implantation of a balloon-expandable transcatheter valve into the inferior vena cava (CAVI) vs medical therapy.

Interventions for valvular disease and heart failure

Outcomes in nonagenarians undergoing transcatheter aortic valve implantation: a nationwide analysis
Deharo P, Bisson A, Herbert J, Lacour T, Saint-Etienne C, Theron A, Porto A, Collart F, Bourguignon T, Cuisset T, Fauchier L
10.4244/EIJ-D-19-00647
free

Editorial comment

Systematic review and meta-analysis of current risk models in predicting short-term mortality after transcatheter aortic valve replacement
Siddiqi T, Usman M, Khan M, Khan M, Riaz H, Khan S, Murad M, Kavinsky C, Doukky R, Kalra A, Desai M, Bhatt D
10.4244/EIJ-D-19-00636
free
Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a randomised controlled trial
Dreger H, Mattig I, Hewing B, Knebel F, Lauten A, Lembcke A, Thoenes M, Roehle R, Stangl V, Landmesser U, Grubitzsch H, Stangl K, Laule M
10.4244/EIJ-D-19-00901
free

Coronary interventions

Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial
Mancone M, Cavalcante R, Modolo R, Falcone M, Biondi-Zoccai G, Frati G, Spitzer E, Benedetto U, Blackstone E, Onuma Y, van Geuns R, Diletti R, Serruys PW
10.4244/EIJ-D-19-00208
free

Editorial comment

Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial
Scheller B, Ohlow M, Ewen S, Kische S, Rudolph TK, Clever Y, Wagner A, Richter S, El-Garhy M, Böhm M, Degenhardt R, Mahfoud F, Lauer B
10.4244/EIJ-D-19-00723
free

Editorial comment

Drug-coated balloons for acute myocardial infarction. Ready for prime time?
Alfonso F, Elgendy I, Cortese B
10.4244/EIJV15I17A270
free
The year in review: coronary interventions
Gao C, Wang R, Sharif F, Takahashi K, Ono M, Hara H, Tomaniak M, Kawashima H, Modolo R, van Geuns R, Capodanno D, Byrne RA, Wijns W, Onuma Y, Serruys PW
10.4244/EIJ-D-19-01124
free

Interventions for hypertension and stroke

Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk
Godino C, Melillo F, Bellini B, Mazzucca M, Pivato C, Rubino F, Figini F, Mazzone P, Della Bella P, Margonato A, Colombo A, Montorfano M
10.4244/EIJ-D-19-00507
free

Editorial comment

Two sides of the coin
Holmes D, Alkhouli M
10.4244/EIJV15I17A271
free

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved